It is now within our ability to understand and rapidly develop therapeutic treatments for all manner of diseases. The World is gearing up for a new era of improved healthcare where previously incurable diseases like cancer, Alzheimer’s, and autoimmune diseases will be a thing of the past.

Swiftly emerging technologies that combine artificial intelligence and drug discovery will revolutionise our ability to develop new life-saving treatments. At SilicoGenesis we are driving the development of state-of-the-art technologies as a part of this revolution.

Our technology increases the success rate of biologic drug discovery campaigns in order to bring better therapeutics to patients faster than ever before.

Many drugs don’t make it to patients because of unforeseen issues in development or due to the prohibitive cost of preclinical and clinical testing.

We significantly decrease the time, cost and risk associated with biologic drug discovery by shifting the bulk of development and analysis in silico, allowing us to test only the best candidates in the lab.

Countless individuals still suffer from diseases that could one day be treated with ease, however, the solution is rarely simple. The biology of disease is vast and complex and in order to master it, we need ever advancing technology and better understanding. Powerful machines working alongside human minds will allow us to conquer all diseases.

Disease and illness doesn’t rest and neither do we. Our efforts to improve our existing technologies and to expand new methodologies is an ongoing process. We are constantly working to push the boundaries of what is possible in order to continually develop the best platform for computational drug design.